Liam Ratcliffe is Director of ARVINAS, INC.. Currently has a direct ownership of 0 shares of ARVN, which is worth approximately $0. The most recent transaction as insider was on Nov 05, 2021, when has been sold 24,923 shares (Common Stock) at a price of $90.88 per share, resulting in proceeds of $2,265,002. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Liam Ratcliffe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 05 2021
SELL
Open market or private sale
$2,265,002 $90.88 p/Share
24,923 Reduced 100.0%
0 Common Stock
Nov 05 2021
BUY
Exercise of conversion of derivative security
$512,528 $27.82 p/Share
18,423 Added 42.5%
24,923 Common Stock

Also insider at

PASG
Passage BIO, Inc. Healthcare
ELYM
Eliem Therapeutics, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
UPB
Upstream Bio, Inc.
LR

Liam Ratcliffe

Director
New Haven, CT

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Track Activities on ARVN